Management of recurrent focal segmental glomerulosclerosis (FSGS) post renal transplantation

医学 美罗华 局灶节段性肾小球硬化 血浆置换术 移植 外科 内科学 泌尿科 蛋白尿 免疫学 抗体 淋巴瘤
作者
Hefsa Rashed Al Shamsi,Ihab Sakr Shaheen,David Aziz
出处
期刊:Transplantation Reviews [Elsevier]
卷期号:36 (1): 100675-100675 被引量:7
标识
DOI:10.1016/j.trre.2021.100675
摘要

One of the common GN causing ESKD is focal segmental glomerulosclerosis (FSGS). Recurrence of FSGS post-transplantation can lead to graft loss. Data on management either prophylactically or once recurrence occurs are limited. This review article aims to assess the effective management of patients with FSGS recurrence post-transplantation, looking mainly at recurrence post prophylactic treatment and remission in case of treatment post recurrence.Twenty-three studies were included using the search MeSH terms "FSGS" "recurrence" "adults" "transplantation" "treatment". Search engines used were Pubmed, clinical key, Scopus and Cochrane library. Inclusion criteria were articles covered adult patients with recurrent FSGS post renal transplantation, treatment with rituximab and plasmapheresis, and articles published from 2000 tt2021. Excluded articles were paediatric population, studies with no reported outcomes of the treatment of FSGS, and Patients who received stem cell transplantation or galactose therapy.Prophylactic PP did not show a reduction in recurrence of FSGS in 2/3 studies. Prophylactic rituximab was shown to reduce recurrence of FSGS in one-study and case reports. Treatment of recurrent FSGS with PP showed responses ranging from 41% to 100%. Only one study did not show improvement with PP use as treatment having a 27% remission. Treatment with rituximab showed variable results, with reports showing remission ranging from 57% to 100%. Whereas other reports showing no response at all. PP prescription reporting was variable. One study suggested intensified PP regimen while in most other studies PP was guided by the response reflected by the reduction of proteinuria.Reviewing the treatment of recurrent FSGS is crucial, as there no consensus on treating FSGS as the disease is not very common in the adult population. The evidence of different modalities is based on small cohort studies. This paper supports the use of PP and RTX as treatment of recurrent FSGS.In conclusion, PP and RTX are the main modalities to treat recurrent FSGS with varying response rates. Prophylactic PP does not play a role in preventing recurrent FSGS. Prophylactic rituximab might play a role in preventing FSGS post-transplantation. PP and RTX, when used as a treatment, show variable response rates. Larger RCTs are needed to have a strong level of evidence to base our clinical management on.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
丘比特应助海带采纳,获得10
2秒前
3秒前
落寞丹萱发布了新的文献求助10
3秒前
山海之间完成签到,获得积分10
4秒前
TRY发布了新的文献求助10
4秒前
生姜完成签到 ,获得积分10
4秒前
2041完成签到,获得积分10
6秒前
飘逸踏歌完成签到 ,获得积分0
9秒前
充电宝应助落寞丹萱采纳,获得10
9秒前
yanshapo发布了新的文献求助10
10秒前
脑洞疼应助发疯的游子采纳,获得10
12秒前
888发布了新的文献求助20
12秒前
SYLH完成签到,获得积分0
13秒前
lrj完成签到,获得积分20
13秒前
海带完成签到,获得积分10
13秒前
天天快乐应助笨笨的晓夏采纳,获得10
14秒前
高大小懒猪完成签到,获得积分10
15秒前
18秒前
大气的火龙果完成签到 ,获得积分10
18秒前
Charles完成签到,获得积分10
18秒前
薛洁洁的小糖应助888采纳,获得50
18秒前
紫色水晶之恋完成签到 ,获得积分10
20秒前
yanshapo完成签到,获得积分10
23秒前
25秒前
山海发布了新的文献求助10
25秒前
大海的DOI完成签到,获得积分10
26秒前
26秒前
火星上白羊完成签到 ,获得积分10
31秒前
小蘑菇应助科研通管家采纳,获得10
31秒前
研友_VZG7GZ应助科研通管家采纳,获得10
31秒前
梁三柏应助科研通管家采纳,获得20
31秒前
田様应助科研通管家采纳,获得10
31秒前
31秒前
桐桐应助科研通管家采纳,获得10
31秒前
汉堡包应助科研通管家采纳,获得10
31秒前
赤木完成签到 ,获得积分10
32秒前
海带发布了新的文献求助10
33秒前
女神金完成签到,获得积分10
34秒前
36秒前
山海完成签到,获得积分10
37秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Les Mantodea de Guyane Insecta, Polyneoptera 1000
Structural Load Modelling and Combination for Performance and Safety Evaluation 1000
Conference Record, IAS Annual Meeting 1977 820
England and the Discovery of America, 1481-1620 600
電気学会論文誌D(産業応用部門誌), 141 巻, 11 号 510
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3572296
求助须知:如何正确求助?哪些是违规求助? 3142501
关于积分的说明 9448015
捐赠科研通 2843973
什么是DOI,文献DOI怎么找? 1563103
邀请新用户注册赠送积分活动 731630
科研通“疑难数据库(出版商)”最低求助积分说明 718640